In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
After a decade of clinical trials, gene therapy seems to have found its place between excessive ambitions and feasible aims, with encouraging results obtained in recent years. Intracellular delivery of genetic material is the key step in gene therapy. Optimization of delivery vectors is of major importance for turning gene therapy into a successful therapeutic method. Nonviral gene delivery relies mainly on the complexes formed from cationic liposomes (or cationic polymers) and DNA, i.e., lipoplexes (or polyplexes). Many lipoplex formulations have been studied, but in vivo activity is generally low compared to that of viral systems. This review gives a concise overview of studies on the application of cationic liposomes in vivo in animal models of diseases and in clinical studies. The transfection efficiency, the pharmacokinetic and pharmacodynamic properties of the lipid-DNA complexes, and potentially relevant applications for cationic liposomes are discussed. Furthermore, the toxicity of, and the induction of an inflammatory response in association with the administration of lipoplexes are described. Increasing understanding of lipoplex behavior and gene transfer capacities in vivo offers new possibilities to enhance their efficiency and paves the path to more extensive clinical applications in the future.
- M. Laitinen, J. Hartikainen, M. O. Hiltunen, J. Eranen, M. Kiviniemi, O. Narvanen, K. Makinen, H. Manninen, M. Syvanne, J. F. Martin, M. Laakso, and S. Yla-Herttuala. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum.Gene Ther. 11:263-270 (2000).
- P. L. Felgner, T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc.Natl.Acad.Sci.USA 84:7413-7417 (1987).
- S. Audouy and D. Hoekstra. Cationic lipid-mediated transfection in vitro and in vivo. Mol.Membr.Biol. 18:129-143 (2001).
- D. Lew, S. E. Parker, T. Latimer, A. M. Abai, A. Kuwahara-Rundell, S. G. Doh, Z.-Y. Yang, D. Laface, S. H. Gromkowski, G. J. Nabel, M. Manthorpe, and J. Norman. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum.Gene Ther. 6:553-564 (1995).
- N. Smyth Templeton, D. D. Lasic, P. M. Frederik, H. H. Strey, D. D. Roberts, and G. N. Pavlakis. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nature Biotechnol. 15:647-652 (1997).
- S. E. Parker, S. Ducharme, J. Norman, and C. J. Wheeler. Tissue distribution of the cytofectin component of a plasmid DNA/cationic lipid complex following intravenous administration in mice. Hum.Gene Ther. 8:393-401 (1997).
- R. Niven, R. Pearlman, T. Wedeking, J. Mackeigan, P. Noker, L. Simpson-Herren, and J. G. Smith. Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice. J.Pharm.Sci. 87:1292-1299 (1998).
- J. W. McLean, E. A. Fox, P. Baluk, P. B. Bolton, A. Haskell, R. Pearlman, G. Thurston, E. Y. Umemoto, and D. McDonald. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am.J.Physiol. 273:H387-H404 (1997).
- L. S. Uyechi, L. Gagne, G. Thurston, and F. C. J. Szoka. Mechanism of lipoplex gene delivery to mouse lung: binding and internalization of fluorescent lipid and DNA components. Gene Ther. 8:828-836 (2001).
- F. Liu, H. Qi, L. Huang, and D. Liu. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther. 4:517-523 (1997).
- Y. K. Song, F. Liu, S. Chu, and D. Liu. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum.Gene Ther. 8:1585-1594 (1997).
- N. Zhu, D. Liggitt, Y. Liu, and R. Debs. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261:209-211 (1993).
- Y. Liu, L. C. Mounkes, H. D. Liggit, C. S. Brown, I. Solodin, T. D. Heath, and R. J. Debs. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotechnol. 15:167-173 (1997).
- L. G. Barron, L. S. Uyechi, and F. C. J. Szoka. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes. Gene Ther. 6:1179-1183 (1999).
- L. C. Mounkes, W. Zhong, G. Cipres-Palacin, T. D. Heath, and R. J. Debs. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro andin vivo. J.Biol.Chem. 273:26164-26170 (1998).
- L. G. Barron, L. Gagne, and F. C. J. Szoka. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. Hum.Gene Ther. 10:1683-1694 (1999).
- R. I. Mahato, K. Anwer, F. Tagliaferri, C. Meaney, P. Leonard, M. S. Wadhwa, M. Logan, M. French, and A. Rolland. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum.Gene Ther. 9:2083-2099 (1998).
- S. Li, S.-P.Wu, M. Whitmore, E. J. Loeffert, L. Wang, S. C. Watkins, B. R. Pitt, L. Huang. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipid vectors. Am J Physiol 276:L796-L804 (1999).
- L. Mohr, S. K. Yoon, S. J. Eastman, Q. Chu, R. K. Scheule, P. P. Scaglioni, M. Geissler, T. Heintges, H. E. Blum, and J. R. Wands. Cationic Liposomes as Vectors for Gene Therapy 1603 Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice. Hum.Gene Ther. 12:799-809 (2001).
- T. Nomura, S. Nakajima, K. Kawabata, F. Yamashita, Y. Takakura, and M. Hashida. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res. 57:2681-2686 (1997).
- T. Nomura, K. Yasuda, T. Yamada, S. Okamoto, R. I. Mahato, Y. Watanabe, Y. Takakura, and M. Hashida. Gene expression and antitumor effects following direct interferon (IFN)-? gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice. Gene Ther. 6:121-129 (1999).
- P. R. Clark, A. T. Stopeck, M. Ferrari, S. E. Parker, and E. M. Hersh. Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA. Cancer Gene Ther. 7:853-860 (2000).
- P. R. Clark, A. T. Stopeck, S. E. Parker, and E. M. Hersh. Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft. Cell.Immunol. 204:96-104 (2000).
- N. Yerushalmi, U. Brinkmann, E. Brinkmann, L. Pai, and I. Pastan. Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes. Cancer Gene Ther. 7:91-96 (2000).
- N. K. Egilmez, R. Cuenca, S. J. Yokota, F. Sorgi, and R. B. Bankert. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery. Gene Ther. 3:607-614 (1996).
- S. E. Parker, S. Khatibi, M. Margalith, D. Anderson, M. Yankauckas, S. H. Gromkowski, T. Latimer, D. Lew, M. Marquet, M. Manthorpe, P. Hobart, E. Hersh, A. T. Stopeck, and J. Norman. Plasmid DNA gene therapy: studies with the human interleukin-2 gene into tumor cells in vitro and in the murine B16 melanoma modelin vivo. Cancer Gene Ther. 3:175-185 (1996).
- E. Galanis, E. M. Hersh, A. T. Stopeck, R. Gonzales, P. Burch, C. Spier, E. T. Akporiaye, J. J. Rinehart, J. Edmonson, R. E. Sobol, C. Forscher, V. K. Sondak, B. D. Lewis, E. C. Unger, M. O'Driscoll, L. Selk, and J. Rubin. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience. J.Clin.Oncol. 17:3313-3323 (1999).
- S. J. Eastman, M. J. Lukason, J. D. Tousignant, H. Murray, M. D. Lane, J. A. St. George, G. Y. Akita, M. Cherry, S. H. Cheng, and R. K. Scheule. A concentrated and stable aerosol formulation of cationic lipid: DNA complexes giving high-level gene expression in mouse lung. Hum.Gene Ther. 8:765-773 (1997).
- J. E. Duncan, J. A. Whitsett, and D. Horowitz. Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cellsin vitro. Hum.Gene Ther. 8:431-438 (1997).
- U. Griesenbach, A. Chonn, R. Cassady, V. Hannam, C. Ackerley, M. Post, A. K. Tanswel, K. Olek, H. O'Brodovich, and L.-C. Tsui. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy. Gene Ther. 5:181-188 (1998).
- S. C. Hyde, D. R. Gill, C. F. Higgins, A. E. O. Trezise, L. J. MacVinish, A. W. Cuthbert, R. Ratcliff, M. J. Evans, and W. H. Colledge. Correction of the ion transport defect in cystic fibrosis mice by gene therapy. Nature 362:250-255 (1993).
- D. J. Porteous, J. R. Dorin, G. McLachlan, H. Davidson-Smith, H. Davidson, B. J. Stevenson, A. D. Carothers, W. A. Wallace, S. Moralee, C. Hoenes, G. Kallmeyer, U. Michaelis, K. Naujoks, L. P. Ho, J. M. Samways, M. Imrie, A. P. Greening, and J. A. Innes. Evidence for safety and efficacy of DOTAP cationic liposome mediated CRTF gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4:210-218 (1997).
- E. W. Alton, M. Stern, R. Farley, A. Jaffe, S. L. Chadwick, J. Phillips, M. G. Davies, M. E. Hodson, S. R. Durham, D. Li, P. K. Jeffery, M. Scallan, R. Balfour, S. J. Eastman, S. H. Cheng, A. E. Smith, D. Meeker, and D. M. Geddes. Cationic lipid-mediated CRTF gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 253:947-954 (1999).
- E. S. Scott, J. W. Wiseman, M. J. Evans, and W. H. Colledge. Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J.Gene Med. 3:125-134 (2001).
- K. L. Brigham, K. B. Lane, B. Meyrick, A. A. Stecenko, S. Strack, D. R. Cannon, M. Caudill, and A. E. Canonico. Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin deficent subjects: comparison with protein therapy. Hum.Gene Ther. 11:1023-1032 (2000).
- J. Hartikka, V. Bozoukova, M. Ferrari, L. Sukhu, J. Enas, M. Sawdey, M. K. Wloch, K. Tonsky, J. Norman, M. Manthorpe, and C. J. Wheeler. Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. Vaccine 19:1911-1923 (2001).
- Y. Perrie, P. M. Frederik, and G. Gregoriadis. Liposomemediated DNA vaccination: the effect of vesicle composition. Vaccine 19:3301-3310 (2001).
- L. S. Klavinskis, C. Barnfield, L. Gao, and S. Parker. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J.Immunol. 162:254-262 (1999).
- J. D. Toussignant, A. L. Gates, L. A. Ingram, C. L. Johnson, J. B. Nietupski, S. H. Chen, S. J. Eastman, and R. K. Scheule. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: plasmid DNA complexes in mice. Hum.Gene Ther. 11:2493-2513 (2000).
- S. Loisel, C. Le Gall, L. Doucet, C. Ferec, and V. Floch. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum.Gene Ther. 12:685-696 (2001).
- S. Dokka, D. Toledo, X. Shi, V. Castranova, and Y. Rojanasakul. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm.Res. 17:521-525 (2000).
- F. E. Ruiz, J. P. Clancy, M. A. Perricone, Z. Bebok, J. S. Hong, S. H. Cheng, D. P. Meeker, K. R. Young, R. A. Schoumacher, M. R. Weatherly, L. Wing, J. E. Morris, L. Sindel, M. Rosenberg, F. W. van Ginkel, J. R. McGhee, D. Kelly, R. K. Lyrene, and E. J. Sorscher. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum.Gene Ther. 12:751-761 (2001).
- R. de Kanter, M. Monshouwer, D. K. Meijer, and G. M. Groothuis. Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to nonhepatic tissues. Curr.Drug Metab. 1:39-59 (2002).
- R. K. Scheule, J. A. St. George, R. G. Bagley, J. Marshall, J. M. Kaplan, G. Y. Akita, K. X. Wang, E. R. Lee, D. J. Harris, C. Jiang, N. S. Yew, A. E. Smith, and S. H. Cheng. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum.Gene Ther. 8:689-707 (1997).
- J. L. Bramson, C. A. Bodner, and R. W. Graham. Activation of host antitumoral responses by cationic lipid/DNA complexes. Cancer Gene Ther. 7:353-359 (2000).
- M. Whitmore, S. Li, and L. Huang. LPD lipoplexes initiates a potent cytokine response and inhibits tumor growth. Gene Ther. 6:1867-1875 (1999).
- S. W. Dow, R. E. Elmslie, L. G. Fradkin, D. H. Liggit, T. D. Heath, A. P. Willson, and T. A. Potter. Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases. Hum.Gene Ther. 10:2961-2972 (1999).
- B. D. Freimark, H. P. Blezinger, V. J. Florack, J. L. Nordstrom, S. D. Long, D. S. Deshpande, S. Nochumson, and K. L. Petrak. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. J.Immunol. 160:4580-4586 (1998).
- A. Gautman, C. L. Densmore, and J. C. Waldrep. Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther. 8:254-257 (2001).
- G. J. Weiner. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J.Leukocyte Biol. 68:455-463 (2000).
- J. Norman, W. Denham, D. Denham, J. Yang, G. Carter, A. Abouhamze, C. L. Tannahill, S. L. MacKay, and L. L. Moldawer. Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammation. Gene Ther. 7:1425-1430 (2000).
- J. E. Baatz, Y. Zou, and T. R. Korfhagen. Inhibitory effects of Audouy, de Leij, Hoekstra, and Molema 1604 tumor necrosis factor-? on cationic lipid-mediated gene delivery to airway cells in vitro. Biochim.Biophys.Acta 1535:100-109 (2001).
- L. Qin, Y. Ding, D. R. Pahud, E. Chang, M. J. Imperiale, and J. S. Bromberg. Promoter attenuation in gene therapy: interferon-? and tumor necrosis factor-? inhibit transgene expression. Hum.Gene Ther. 8:2019-2029 (1997).
- Y. Tan, F. Liu, Z. Li, S. Li, and L. Huang. Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol.Ther. 3:673-682 (2001).
- S. W. Dow, L. G. Fradkin, D. H. Liggitt, A. P. Willson, T. D. Heath, and T. A. Potter. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J.Immunol. 163:1552-1561 (1999).
- Y. Liu, A. Thor, E. Shtivelman, Y. Cao, G. Tu, T. D. Heath, and R. J. Debs. Systemic gene delivery expands the repertoire of effective antiangiogenic agents. J.Biol.Chem. 274:13338-13344 (1999).
- A. Natsume, M. Mizuno, Y. Ryuke, and J. Yoshida. Antitumor effect and cellular immunity activation by murine interferon-? gene transfer against intracerebral glioma in mouse. Gene Ther. 6:1626-1633 (1999).
- In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy
Volume 19, Issue 11 , pp 1599-1605
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- gene therapy
- cationic liposomes
- Industry Sectors
- Author Affiliations
- 1. Department of Membrane Cell Biology, Groningen University Institute for Drug Exploration (GUIDE), Groningen, The Netherlands
- 2. Department of Pathology and Laboratory Medicine, Medical Biology Section, Tumor Immunology Laboratory, Groningen University Institute for Drug Exploration (GUIDE), Groningen, The Netherlands